Aptose Biosciences Eulerpool naujienos

Aptose Biosciences Eulerpool News

Aptose Biosciences akcijų naujienos

Aptose Biosciences stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Aptose Biosciences naujienas mes pateikiame čia.

• rugsėjo 5 d. ·

  Yahoo
  Aptose Announces Results from Special Meeting of Shareholders
• rugsėjo 2 d. ·

  Yahoo
  Aptose Biosciences secures funds for AML treatment development
• rugpjūčio 30 d. ·

  Yahoo
  Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib
• rugpjūčio 15 d. ·

  Yahoo
  Aptose Announces Adjournment of its Special Meeting of Shareholders
• rugpjūčio 9 d. ·

  Yahoo
  Aptose Biosciences: Q2 Earnings Snapshot
• rugpjūčio 8 d. ·

  Yahoo
  Aptose Reports Results for the Second Quarter 2024
• liepos 19 d. ·

  Yahoo
  Aptose Announces Receipt of Deficiency Notice from Nasdaq
• birželio 18 d. ·

  Yahoo
  Aptose Announces Results from Annual and Special Meeting of Shareholders
• birželio 14 d. ·

  Yahoo
  Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
• birželio 13 d. ·

  Yahoo
  Aptose Biosciences (APTO) Upgraded to Buy: What Does It Mean for the Stock?